Detailed price information for Rocket Lab Corporation (RKLB-Q) from The Globe and Mail including charting and trades.

FDA-cleared imaging platform, cash burn and dilution risks, and 2026 execution hurdles—read now before May 20 Q1 results.

Even after the drop, valuation is not cheap versus the benchmarks cited. DUOL trades at 34.62 times forward 12-month earnings, versus 23.01 times for the industry. The five-year median forward ...

Advances Nanox’s ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in ...

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws. The articles, information, and content displayed on ...

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX). Such investors are advised ...

LOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nano-X Imaging ...

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws. The articles, information, and content displayed on ...

Shares of Nano-X Imaging (NNOX) lost ~17% on Monday, on track to what could be its worst intraday decline in over two years after the Israeli MedTech reported lower-than-expected Q4 2025 results ...

International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings PETACH TIKVA, ISRAEL -16 April, 2026 ...